Cargando…
Development of Microencapsulation Delivery System for Long-Term Preservation of Probiotics as Biotherapeutics Agent
The administration of probiotic bacteria for health benefit has rapidly expanded in recent years, with a global market worth $32.6 billion predicted by 2014. The oral administration of most of the probiotics results in the lack of ability to survive in a high proportion of the harsh conditions of ac...
Autores principales: | Solanki, Himanshu K., Pawar, Dipak D., Shah, Dushyant A., Prajapati, Vipul D., Jani, Girish K., Mulla, Akil M., Thakar, Prachi M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763591/ https://www.ncbi.nlm.nih.gov/pubmed/24027760 http://dx.doi.org/10.1155/2013/620719 |
Ejemplares similares
-
The efficacy of three double-microencapsulation methods for preservation of probiotic bacteria
por: Pupa, Pawiya, et al.
Publicado: (2021) -
Designer Probiotics: The Next-Gen High Efficiency Biotherapeutics
por: Singh, Birbal, et al.
Publicado: (2019) -
The Emerging Biotherapeutic Agent: Akkermansia
por: Kalia, Vipin Chandra, et al.
Publicado: (2021) -
Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells
por: Prakash, Satya, et al.
Publicado: (2008) -
Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases
por: Kumar, Manoj, et al.
Publicado: (2012)